Interviews with the world’s key opinion leaders in cancer

TagClinical Oncology

Luis Paz-Ares MD PhD: Longer Survival Among Patients with Extensive Stage Small Cell Lung Cancer Treated with Lurbinectedin Maintenance —ASCO 2025

11 months ago

Audio Journal of Oncology An interview with: Luis G Paz-Ares MD PhD, Chair of Medical Oncology, Hospital Universitario 12 de Octubre, Universitario...

Oncology Video

Orteronel shows no survival advantage in metastatic castration-resistant prostate cancer: phase III randomized study finds

February 6, 2014

SAN FRANCISCO—Orteronel — a non-steroidal selective inhibitor of 17,20-lyase — did not achieve a significant improvement in overall survival in 1099...

TagClinical Oncology

Luis Paz-Ares MD PhD: Longer Survival Among Patients with Extensive Stage Small Cell Lung Cancer Treated with Lurbinectedin Maintenance —ASCO 2025

Orteronel shows no survival advantage in metastatic castration-resistant prostate cancer: phase III randomized study finds

Menu